1)Gunderson LL, Jessup JM, Sargent DJ, et al:Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes. J Clin Oncol 28:256-263, 2010
2)Gunderson LL, Jessup JM, Sargent DJ, et al:Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol 28:264-271, 2010
3)Matsuda C, Ishiguro M, Teramukai S, et al:A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafureuracil versus surgery alone in stage Ⅱ colon cancer:SACURA trial. Eur J Cancer 96:54-63, 2018
4)大腸癌研究会編:大腸癌治療ガイドライン 医師用2019年版.金原出版,2019
5)Kotake K, Honjo S, Sugihara K, et al:Number of lymph nodes retrieved is an important determinant of survival of patients with stage Ⅱ and stage Ⅲ colorectal cancer. Jpn J Clin Oncol 42:29-35, 2012
6)Ueno H, Ishiguro M, Nakatani E, et al:A Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage Ⅱ Colon Cancer:Results from the SACURA Trial. J Clin Oncol(in press)
7)Shinto E, Hida JI, Kobayashi H, et al:Prominent Information of jN3 Positive in Stage Ⅲ Colorectal Cancer Removed by D3 Dissection:Retrospective Analysis of 6866 Patients From a Multi-institutional Database in Japan. Dis Colon Rectum 61:447-453, 2018
8)Shinto E, Hida JI, Ike H, et al:A New N Staging System for Colorectal Cancer in the Era of Extended Lymphadenectomy. Ann Surg Oncol 25:3891-3897, 2018
9)Ueno H, Mochizuki H, Shirouzu K, et al:Actual status of distribution and prognostic impact of extramural discontinuous cancer spread in colorectal cancer. J Clin Oncol 29:2550-2556, 2011
10)Shinto E, Ike H, Hida JI, et al:Marked impact of tumor location on the appropriate cutoff values and the prognostic significance of the lymph node ratio in stage Ⅲ colon cancer:a multi-institutional retrospective analysis. J Gastroenterol(in press)